4.0 Review

Sugar sweetened beverages intake and risk of obesity and cardiometabolic diseases in longitudinal studies: A systematic review and meta-analysis with 1.5 million individuals

期刊

CLINICAL NUTRITION ESPEN
卷 51, 期 -, 页码 128-142

出版社

ELSEVIER
DOI: 10.1016/j.clnesp.2022.08.021

关键词

Sweetened drinks; Non -communicable chronic diseases; Prospective studies; Meta -analysis

资金

  1. Brazilian National Research Council (CNPq)
  2. [442801/2019-0]

向作者/读者索取更多资源

The study found through a systematic review and meta-analysis that the consumption of sugar-sweetened beverages (SSB) appeared to increase the risk of obesity and cardiometabolic diseases, with the strongest association observed with type 2 diabetes.
Background: Sugar-sweetened beverages (SSB) are associated with adverse outcomes in adults and understanding the strength, consistency and biological gradient of the association between SSB con-sumption and health-related outcomes is important. We aimed to examine longitudinal associations between sugar-sweetened beverages (SSB) intake and obesity and cardiometabolic diseases (type 2 diabetes, coronary heart disease and stroke) in adults.Methods: We performed a systematic review and meta-analysis searching for articles published until December 2021 in the Pubmed, Lilacs, Web of Science, Cochrane, Embase, and Scopus databases (PROSPERO CRD42021234206).Results: After screening of more than 18 thousand titles and abstracts, 27 longitudinal studies were included in the review with all of them presenting medium or high methodological quality. None of the selected studies were from low-income countries and only three were conducted in middle-income countries. Type 2 diabetes was the most investigated disease -outcome in 15 out of 27 studies. Around 80% of the studies enrolled more than 10,000 individuals in the sample, and almost half of them followed the subjects for less than 10 years. A total of 1.5 million individuals were included in the pooled analyses, and results indicated that SSB intake increased the risk of type 2 diabetes (RR = 1.20; 95% C.I. 1.13-1.28), obesity (RR = 1.17; 95% C.I. 1.10-1.25), coronary heart disease (RR = 1.15; 9% C.I. 1.06-1.25), and stroke (RR = 1.10; 9% C.I. 1.01-1.19) in adults after adjustment for all potential confounders.Conclusion: Our systematic review and meta-analysis demonstrated that consumption of SSB intake appears to increase the risk obesity and cardiometabolic diseases, being the strongest evidence for type 2 diabetes. Actions are needed to be taken to reduce the SSB intake and its consequences worldwide.(c) 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据